return to news
  1. LatentView share price jumps over 8% after its US-based arm invests $3 million in AI startup

Market News

LatentView share price jumps over 8% after its US-based arm invests $3 million in AI startup

Anubhav Mukherjee

4 min read | Updated on April 02, 2026, 12:10 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

LatentView shares jumped more than 8% on Thursday, April 2, after the company's US-based subsidiary signed an agreement to invest $3 million in an artificial intelligence (AI) startup. The deal is carried out in the form of SAFE notes, actionable in a future funding round.

Stock list

LatentView shares surged 8.6% to hit their intraday high of ₹283.80 during the market session on April 2.

LatentView shares surged 8.6% to hit their intraday high of ₹283.80 during the market session on April 2.

Global digital analytics firm, LatentView Analytics, shares jumped more than 8% during the stock market session on Thursday, April 2, after the company announced that its US-based subsidiary has signed an agreement to invest $3 million in an artificial intelligence (AI) startup which caters to healthcare industry clients.

Open FREE Demat Account within minutes!
Join now

In its NSE filing on early Thursday, LatentView Analytics disclosed that its New Jersey-based subsidiary, LatentView Analytics Corp., has executed a deal via SAFE notes on April 1, for investing $3 million in Healtheon AI Inc.

“We wish to inform that M/s. LatentView Analytics Corporation, a material & wholly owned subsidiary of the company, has executed a Simple Agreement for Future Equity Notes (SAFE Notes) on April 01, 2026, for a strategic investment of $3,000,000 in M/s. Healtheon AI Inc. (a Delaware Corporation),” the company informed the stock exchange.

LatentView shares surged 8.6% to hit their intraday high of ₹283.80 during the market session on April 2, compared to ₹261.20 at the previous stock market close, according to NSE data.

$3 million deal details

LatentView Analytics Corporation is investing $3 million in an AI startup, Healtheon AI Inc., through SAFE notes. These Simple Agreement for Future Equity notes, or SAFE notes, are a form of agreement where the company gives the money for a future stake in the company.

The investment outlay, which is set to be completed on or before April 7, 2026, comes as the company aims to secure a stake in a high-moat, AI-agentic framework, targeting the Revenue Cycle Management sector in the market.

This deal will give LatentView Analytics the option to convert its investment into SAFE preferred stock of Healtheon AI in case of a future funding round raised by the company or any other triggers which they deem fit per the agreement.

The company also disclosed that the entire $3 million deal will be in an all cash consideration, and as the investment in form of SAFE notes, then there is no immediate acquisition of shares or voting rights in the company.

LatentView Analytics share price

LatentView Analytics shares were trading 7.52% higher at ₹280.85 as of 11:46 am on Thursday, compared to ₹261.20 at the previous stock market close, NSE data showed. The company announced the update ahead of the opening bell on April 2.

Shares of the company have lost over 12% in the last three years and more than 24% in the last one year period, according to NSE data. On a year-to-date (YTD) basis in 2026, the company’s stock has dropped 38.44% in 2026, and is down 14.26% in the last month.

However, the exchange data showed that LatentView shares were trading 3.34% higher in the last five market sessions on the Indian stock market.

LatentView stock hit its 52-week high at ₹517.50 on December 8, 2025, while the 52-week low was at $248 on March 23, 2026, according to the NSE data. The company’s market capitalisation (M-Cap) was at ₹6,078.42 crore as of the stock market session on Thursday, April 2, 2026.

LatentView Q3 results

LatentView Analytics’ net profit for the October to December quarter witnessed a 19% rise to ₹50.77 crore, compared year-on-year (YoY) with ₹42.61 crore in the same period the previous fiscal year, according to the consolidated financial statements released in early February 2026.

The company’s revenue from core operations rose 22% to ₹278 crore in the third quarter, compared to its ₹227.83 crore level in the same quarter of the previous financial year, according to the NSE filing.

Overall, the company’s earnings per share (EPS) also improved to 2.43, compared to its earlier 2.03 level in the previous year.

Disclaimer: This article is purely for informational purposes and should not be considered investment advice from Upstox. Please consult with a financial advisor before making any investment decisions.
To add Upstox News as your preferred source on Google, click here.

About The Author

Anubhav Mukherjee
Anubhav Mukherjee is a business journalist with two years of experience at leading financial news platforms. He writes on a wide range of topics, including equity markets, corporate developments, company earnings and commodities. He holds a Post Graduate Diploma in Business & Financial Journalism by Bloomberg from the Asian College of Journalism.

Next Story